BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20241005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260722T170000
DTEND;TZID=Australia/Sydney:20260722T170000
DTSTAMP:20260505T060230Z
CREATED:20260505T060230Z
LAST-MODIFIED:20260505T060230Z
UID:10000292-1784739600-1784739600@melanoma.org.au
SUMMARY:MRFF BioMedTech Incubator
DESCRIPTION:The MRFF 2026 BioMedTech Incubator Program provides grants of financial assistance to support medical research and medical innovation projects through the establishment of BioMedTech Incubators. \nThis grant is for an eligible organisation who can establish a working incubator\, to partner with Australian small and medium enterprises (SMEs) to progress new and innovative medical research projects through the early stages of development. \nThe 2026 BioMedTech Grant Opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative. \nThis opportunity looks to fund suitable organisations to identify\, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects that have commercial potential. \nThe intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers\, diagnostics\, therapeutics\, assistive devices and/or digital technologies that have progressed through the early stages of research and development to the point where they are ‘de-risked’ and attractive to private investment for commercialisation. \nApplicants may propose to support development of innovations in their area/s of strength (i.e. applicants are not required to propose a program that covers the breadth of the biomedtech sector). \nGrants of up to $33 million to establish BioMedTech Incubators. \n\nKey Dates\nApplications close: 22 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-incubator/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Incubator-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260714T170000
DTEND;TZID=Australia/Sydney:20260714T170000
DTSTAMP:20260505T055930Z
CREATED:20260505T055930Z
LAST-MODIFIED:20260505T055930Z
UID:10000291-1784048400-1784048400@melanoma.org.au
SUMMARY:MRFF National Critical Research Infrastructure
DESCRIPTION:The 2026 National Critical Research Infrastructure initiative invests in research infrastructure to ensure Australian researchers find innovative solutions to complex health problems in areas of unmet medical need. This grant opportunity has four streams. \nStream 1 – Innovation enablers\nAddress an area of unmet medical need by promoting the development and implementation of new research infrastructure by supporting development and/or expansion of research enablers such as biobanks\, tissue repositories\, novel platforms\, and secure health data environments to create valuable research resources. \nStream 2 – Digitisation of health care\nTranslate or implement innovative artificial intelligence technologies into health applications that: \n\nbenefit multiple health disciplines/areas\ninvolve consumers in the research journey to ensure the research is applicable to the needs of the Australian community; and\nincrease artificial intelligence workforce capacity and capability\, particularly in relation to health\, through cross-sector and interdisciplinary collaboration.\n\nStream 3 – Co-investment partnerships\nUtilise co-investment (cash only) with the research sector\, state and/or territory governments\, and industry\, in significant critical research infrastructure (e.g. facilities\, personnel and equipment): \n\nto support development of research capacity\, capability and/or effectiveness in an area of unmet medical need\, or\nto enable Australian research using new platforms\, systems and services in an area of unmet medical need.\n\nStream 4 – mRNA technology enablers\nLeverage and enhance emerging mRNA technologies\, platforms\, and/or equipment to accelerate development of mRNA-based vaccines and therapeutics in an area of unmet medical need. \nGrants to fund research infrastructure projects\, up to $3 million in Streams 1\, 2 and 4\, and up to $7 million in Stream 3. \nAn application may only be submitted to one of the above four streams. Applicants must specify the stream to which they are applying in their application. \n\n\n\nKey Dates\nApplications close: 14 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-research-infrastructure/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Critical-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260401T170000
DTEND;TZID=Australia/Sydney:20260401T170000
DTSTAMP:20260204T042218Z
CREATED:20260203T034803Z
LAST-MODIFIED:20260204T042218Z
UID:10000247-1775062800-1775062800@melanoma.org.au
SUMMARY:MRFF 2025 Clinical Trials Activity
DESCRIPTION:The Medical Research Future Fund (MRFF) Clinical Trials Activity Initiative aims to: \n\nimprove the evidence base supporting clinical care\nhelp patients access trials relevant to their health circumstances\nenable researchers to bring international trials to Australian patients.\n\nThe Medical Research Future Fund (MRFF) – 2025 Clinical Trials Activity Grant Opportunity will support medical research and medical innovation projects that: \n\nStream 1 (Incubator): conduct a pilot study to assess the feasibility of a new clinical trial for one or more treatments and/or management strategies for a rare cancer\, rare disease and/or unmet need.\nStream 2 (Targeted Call for Research): conduct a clinical trial of one or more treatments and/or management-based interventions for rare cancers\, rare diseases and/or unmet need.\nStream 3 (Targeted Call for Research): conduct a clinical trial that supports the delivery of effective and high value care by targeting evidence gaps of value to health technology assessment processes in Australia.\nStream 4 (Targeted Call for Research): conduct a prevention clinical trial aimed at reducing the risk\, onset or progression of disease through early intervention strategies.\n\nThe intended outcome of the research is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality\, evidence-based and effective health care. \nThis grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health\, Disability and Ageing. \nKey Dates \nMinimum data due date: 4 March 2026 \nApplications close: 1 April 2026 \nFunding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-clinical-trials-activity/
CATEGORIES:Grants,Clinical Trial Cohorts
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/MRFF-2025-ClinicalT-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20251211T170000
DTEND;TZID=Australia/Sydney:20251211T170000
DTSTAMP:20251202T032844Z
CREATED:20251202T032647Z
LAST-MODIFIED:20251202T032844Z
UID:10000220-1765472400-1765472400@melanoma.org.au
SUMMARY:MRFF 2025 Research Data Infrastructure Grant
DESCRIPTION:This grant opportunity is part of the Medical Research Future Fund and the Research Data Infrastructure Initiative. It looks to fund the creation or extension of national research data infrastructure to support world-class health and medical research in Australia. \nThe objective of this grant opportunity is to provide grants of financial assistance to support Australian medical research and medical innovation projects that use novel methods to harness multiple existing data infrastructure types in developing and implementing new approaches for addressing an unmet medical need. \nKey Dates\nApplications close: Thursday 11 December 2025\, 5.00pm AEDT \nSEE GRANT GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-2025-data-infrastructure-grant/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2025/11/MRFF.png
END:VEVENT
END:VCALENDAR